Astrazeneca vaccine
More News
-
Bangladesh urges India for immediate release of purchased vaccines
New Delhi assures Dhaka it would help get US vaccines on priority basis, says minister
-
German vaccine seekers getting aggressive, doctors say
Older patients who have been assigned AstraZeneca are also demanding a different vaccine
-
AstraZeneca shot is good if safety issues can be overcome, US official Fauci says
AstraZeneca’s vaccine is by far the cheapest and most high-volume shot launched so far
-
Philippines suspends use of AstraZeneca vaccine for people under 60
Temporary suspension does not mean that the vaccine is unsafe or ineffective
-
AstraZeneca jab has plausible link to blood clots: WHO
Relationship between vaccine, blood clots not confirmed, more studies needed, says WHO advisory committee
-
Oxford pauses Covid-19 vaccine study in kids, awaits more data on blood clot issues
The university said in February it planned to enroll 300 volunteers aged 6-17 years, based in the United Kingdom
-
Australia probes if blood clot case linked to AstraZeneca vaccine
Investigators have not confirmed a causal link with the Covid-19 AstraZeneca vaccine, investigations ongoing
-
Immune response may be linked to AstraZeneca vaccine clot issue
Four previously healthy individuals who got the AstraZeneca shot and developed life-threatening clots
-
EU must be united over Russian, Chinese Covid-19 vaccines: French minister
Europe has so far approved vaccines from Pfizer/BioNTech, Moderna and AstraZeneca/Oxford
-
Explainer-How does AstraZeneca's vaccine compare with Pfizer-BioNTech?
AstraZeneca vaccine’s efficacy in preventing infections was 70.4%, compared with Pfizer/BioNTech's efficacy of 95%
-
WHO vaccine scheme risks failure, leaving poor countries no Covid shots until 2024
Scheme’s promoters say programme is struggling from lack of funds, supply risks and complex contractual arrangements
-
India could authorise Covid-19 vaccines in weeks, 300 million on priority list
Pfizer Inc sought emergency-use authorisation in India, followed by Astra Zeneca’s Covishield vaccine
-
Testing times: More work needed on Astra/Oxford vaccine trials
Both Covid-19 vaccines have more work to do to confirm whether their Covid-19 vaccine can be 90% effective
-
Covid-19 vaccine possible ready by Q1, 2021: Indian official
Remarks came after international biopharmaceutical company AstraZeneca stopped vaccine trials in four countries
-
'So far, so good' on leading Covid vaccine, says AstraZeneca
AstraZeneca’s shot is widely considered the leading candidate after results from human trials showed it was safe